CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
19 hedge funds and large institutions have $883K invested in CASI Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.39K | |
| 2 | +$777 | |
| 3 | +$291 | |
| 4 |
KA
Kozak & Associates
Highlands Ranch,
Colorado
|
+$24 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2 |
Top Sellers
| 1 | -$116K | |
| 2 | -$59.2K | |
| 3 | -$28.5K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$25.8K |
| 5 |
Jane Street
New York
|
-$14.3K |